- Home
- IPG vs QGEN Comparison
IPG vs QGEN Comparison
Compare IPG & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPG
- QGEN
- Stock Information
- Founded
- IPG 1902
- QGEN 1986
- Country
- IPG United States
- QGEN Netherlands
- Employees
- IPG N/A
- QGEN N/A
- Industry
- IPG Advertising
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IPG Consumer Discretionary
- QGEN Health Care
- Exchange
- IPG Nasdaq
- QGEN Nasdaq
- Market Cap
- IPG 8.9B
- QGEN 9.1B
- IPO Year
- IPG N/A
- QGEN 1996
- Fundamental
- Price
- IPG $24.73
- QGEN $47.85
- Analyst Decision
- IPG Buy
- QGEN Buy
- Analyst Count
- IPG 9
- QGEN 9
- Target Price
- IPG $32.50
- QGEN $50.79
- AVG Volume (30 Days)
- IPG 9.2M
- QGEN 1.3M
- Earning Date
- IPG 07-23-2025
- QGEN 07-30-2025
- Dividend Yield
- IPG 5.44%
- QGEN 3.15%
- EPS Growth
- IPG N/A
- QGEN N/A
- EPS
- IPG 1.31
- QGEN 0.42
- Revenue
- IPG $9,001,000,000.00
- QGEN $2,002,874,000.00
- Revenue This Year
- IPG N/A
- QGEN $6.36
- Revenue Next Year
- IPG $2.74
- QGEN $6.18
- P/E Ratio
- IPG $18.45
- QGEN $113.60
- Revenue Growth
- IPG N/A
- QGEN 3.31
- 52 Week Low
- IPG $22.51
- QGEN $37.63
- 52 Week High
- IPG $33.05
- QGEN $48.36
- Technical
- Relative Strength Index (RSI)
- IPG 58.03
- QGEN 71.53
- Support Level
- IPG $23.96
- QGEN $46.37
- Resistance Level
- IPG $24.65
- QGEN $46.83
- Average True Range (ATR)
- IPG 0.57
- QGEN 0.69
- MACD
- IPG 0.19
- QGEN -0.00
- Stochastic Oscillator
- IPG 95.22
- QGEN 89.25
About IPG Interpublic Group of Companies Inc. (The)
Interpublic Group is among the world's largest advertising holding companies based on annual revenue. It provides traditional advertising services along with digital and other services such as public relations through various acquisitions. IPG has made these services available in over 100 countries. The company generates about 65% of revenue in the US and 17% in the UK and Europe. IPG agreed to merge with Omnicom in December 2024, pending regulatory approval.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).